Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Hillevax Inc (HLVX)

Hillevax Inc (HLVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 104,795
  • Shares Outstanding, K 50,141
  • Annual Sales, $ 0 K
  • Annual Income, $ -147,270 K
  • EBIT $ -77 M
  • EBITDA $ -78 M
  • 60-Month Beta 0.77
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.71
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.10
  • Most Recent Earnings $-0.11 on 08/06/25
  • Next Earnings Date 11/06/25
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.52
  • Growth Rate Est. (year over year) +192,215.38%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.05 +1.95%
on 08/18/25
2.13 -1.88%
on 08/25/25
+0.01 (+0.48%)
since 08/15/25
3-Month
1.82 +15.15%
on 06/17/25
2.17 -3.69%
on 07/28/25
+0.23 (+12.37%)
since 06/16/25
52-Week
1.34 +55.97%
on 04/04/25
2.17 -3.69%
on 07/28/25
+0.30 (+16.76%)
since 09/16/24

Most Recent Stories

More News
XOMA Royalty Announces Closing of Tender Offer for HilleVax, Inc.

EMERYVILLE, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA) (“XOMA Royalty” or the “Company”), a biotechnology royalty aggregator playing a distinctive role...

XOMA : 24.90 (-1.43%)
HLVX : 2.09 (-0.48%)
XOMAP : 26.80 (+0.19%)
XOMAO : 25.52 (-0.16%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BASE, HLVX, AVDX on Behalf of Shareholders

NEW YORK , Aug. 20, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

AVDX : 10.00 (unch)
HLVX : 2.09 (-0.48%)
BASE : 24.51 (+0.04%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ARIS, HLVX, AMWD on Behalf of Shareholders

NEW YORK , Aug. 12, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

ARIS : 23.69 (+1.02%)
AMWD : 56.37 (+0.09%)
HLVX : 2.09 (-0.48%)
Shareholder Alert: The Ademi Firm Investigates Whether HilleVax, Inc. Is Obtaining a Fair Price for Its Public Shareholders

The Ademi Firm is investigating HilleVax (NASDAQ: HLVX) for possible breaches of fiduciary duty and other violations of law in its transaction with XOMA Royalty Corporation . ...

HLVX : 2.09 (-0.48%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ARIS, YMAB, HLVX on Behalf of Shareholders

NEW YORK , Aug. 8, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

ARIS : 23.69 (+1.02%)
HLVX : 2.09 (-0.48%)
YMAB : 8.61 (+0.23%)
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of HilleVax, Inc. (NASDAQ: HLVX)

NEW YORK , Aug. 7, 2025 /PRNewswire/ -- Class Action Attorney  Juan Monteverde  with Monteverde & Associates PC  (the "M&A Class Action Firm"),...

HLVX : 2.09 (-0.48%)
HilleVax Reports Second Quarter 2025 Financial Results

BOSTON, Aug. 06, 2025 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today reported financial...

HLVX : 2.09 (-0.48%)
HILLEVAX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of HilleVax, Inc. - HLVX

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC (“KSF”) are investigating the proposed sale of HilleVax , Inc....

XOMA : 24.90 (-1.43%)
HLVX : 2.09 (-0.48%)
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of HilleVax, Inc.

NEW YORK , Aug. 5, 2025 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by HilleVax, Inc. (NASDAQ: HLVX) and its board of directors concerning the...

XOMA : 24.90 (-1.43%)
HLVX : 2.09 (-0.48%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SCS, HNI, LVTX, HLVX on Behalf of Shareholders

NEW YORK , Aug. 4, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

HNI : 43.00 (+1.22%)
SCS : 16.14 (+0.12%)
HLVX : 2.09 (-0.48%)
LVTX : 1.7400 (-3.87%)

Business Summary

HilleVax Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines. Its initial program, HIL-214, is a virus-like particle based vaccine candidate in development for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection....

See More

Key Turning Points

3rd Resistance Point 2.12
2nd Resistance Point 2.12
1st Resistance Point 2.10
Last Price 2.09
1st Support Level 2.08
2nd Support Level 2.08
3rd Support Level 2.06

See More

52-Week High 2.17
Last Price 2.09
Fibonacci 61.8% 1.85
Fibonacci 50% 1.76
Fibonacci 38.2% 1.66
52-Week Low 1.34

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar